Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
This study is ongoing, but not recruiting participants.
Study NCT00025727
Information provided by NIH AIDS Clinical Trials Information Service
First Received: October 15, 2001
Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
